These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37787915)

  • 61. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies.
    Lee WS; Singh G
    J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.
    Singh G
    J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy.
    Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ
    Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
    Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
    Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A multicenter nationwide reference intervals study for common biochemical analytes in Turkey using Abbott analyzers.
    Ozarda Y; Ichihara K; Aslan D; Aybek H; Ari Z; Taneli F; Coker C; Akan P; Sisman AR; Bahceci O; Sezgin N; Demir M; Yucel G; Akbas H; Ozdem S; Polat G; Erbagci AB; Orkmez M; Mete N; Evliyaoglu O; Kiyici A; Vatansev H; Ozturk B; Yucel D; Kayaalp D; Dogan K; Pinar A; Gurbilek M; Cetinkaya CD; Akin O; Serdar M; Kurt I; Erdinc S; Kadicesme O; Ilhan N; Atali DS; Bakan E; Polat H; Noyan T; Can M; Bedir A; Okuyucu A; Deger O; Agac S; Ademoglu E; Kaya A; Nogay T; Eren N; Dirican M; Tuncer G; Aykus M; Gunes Y; Ozmen SU; Kawano R; Tezcan S; Demirpence O; Degirmen E
    Clin Chem Lab Med; 2014 Dec; 52(12):1823-33. PubMed ID: 25153598
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nationwide multicenter study aimed at the establishment of common reference intervals for standardized clinical laboratory tests in Japan.
    Yamamoto Y; Hosogaya S; Osawa S; Ichihara K; Onuma T; Saito A; Banba K; Araki H; Nagamine Y; Shinohara K; Okada G; Matsumoto H; Oguri T; Gonaikawa S; Iwagami M;
    Clin Chem Lab Med; 2013 Aug; 51(8):1663-72. PubMed ID: 23612542
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
    Brito-Zerón P; Retamozo S; Gandía M; Akasbi M; Pérez-De-Lis M; Diaz-Lagares C; Bosch X; Bové A; Pérez-Alvarez R; Soto-Cárdenas MJ; Sisó A; Ramos-Casals M
    J Autoimmun; 2012 Aug; 39(1-2):43-8. PubMed ID: 22297146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
    Ermak N; Nguyen-Khoa T; Alyanakian MA
    Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Establishing paediatric reference intervals for thyroid function tests in Croatian population on the Abbott Architect i2000.
    Bokulić A; Zec I; Marijančević D; Goreta S; Požgaj Šepec M; La Grasta Sabolić L
    Biochem Med (Zagreb); 2021 Oct; 31(3):030702. PubMed ID: 34393595
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Desirable performance characteristics and clinical utility of immunoglobulin and light-chain assays derived from data on biological variation.
    Ford RP; Mitchell PE; Fraser CG
    Clin Chem; 1988 Sep; 34(9):1733-6. PubMed ID: 3138039
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interlaboratory study of free monoclonal immunoglobulin light chain quantification.
    Vávrová J; Maisnar V; Tichý M; Friedecký B; Čermáková Z; Dastych M; Gottwaldová J; Kučera P; Krotká J; Racek J; Ženková J; Schneiderka P; Lochman P; Zima T; Benáková H; Büchler T; Spáčilová J; Hájek R; Palička V
    Clin Chem Lab Med; 2011 Jan; 49(1):89-92. PubMed ID: 21034251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An indirect approach for reference intervals establishment of immunoglobulin A, G and M: the combination of laboratory database and statistics.
    Chai J; Sun Z; Zhang S; Zhou Q; Xu J
    Scand J Clin Lab Invest; 2022 Jul; 82(4):311-322. PubMed ID: 35791063
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology.
    Jagannath S
    Clin Lymphoma Myeloma; 2007 Sep; 7(8):518-23. PubMed ID: 18021469
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A multicenter reference interval study of thromboelastography in the Chinese adult population.
    Zeng X; Fang L; Peng Y; Zhang Y; Li X; Wang Z; Zhang B; Cao Q; Hu X
    Thromb Res; 2020 Nov; 195():180-186. PubMed ID: 32711234
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of immunoglobulin heavy- and light-chain measurements compared with existing techniques as a means of typing monoclonal immunoglobulins.
    Whicher JT; Wallage M; Fifield R
    Clin Chem; 1987 Oct; 33(10):1771-3. PubMed ID: 3117430
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
    Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
    Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Comparative analysis of immunoglobulin free light chains quantification by Freelite™ (The Binding Site) and N Latex FLC (Siemens) methods].
    Schneider N; Wynckel A; Kolb B; Sablon E; Gillery P; Maquart FX
    Ann Biol Clin (Paris); 2013; 71(1):13-9. PubMed ID: 23396425
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis.
    Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H
    Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.